Authors
Loading...
Prospective observational study demonstrates superior cost-effectiveness of enalapril plus amlodipine in newly diagnosed hypertensive patients, suggesting preferred adoption over monotherapies.
Katariya et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: